The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing
Authors:
Open Access
- 15 April 1990
- journal article
- Published by American Society of Hematology in Blood
- Vol. 75 (8) , 1684-1690
Abstract
DNA from 161 patients with various forms of hematologic malignancies were investigated for mutations in exons 1 and 2 of the N-RAS, K-RAS and Ha-RAS gene by direct sequencing of DNA amplified in vitro by the polymerase chain reaction. Mutations involving either codons 11, 12, or 13 of the N-RAS gene were identified in 18 of the 161 patients. The relative frequencies of N-RAS gene mutations in these hematologic disorders was as follows: acute myelogenous leukemia (AML), 15%; acute lymphoblastic leukemia (ALL), 14%; myelodysplastic syndromes, 24%; and myeloid and lymphoid blast crisis of chronic myelogenous leukemia (CML), 3%. No correlation was observed between the presence of mutations and cytologic features or immunophenotype of these malignancies. Mutations involving codons 12 or 13 were equally prevalent, with a glycine to aspartic acid substitution being the most frequently encountered change. A single T-ALL case had a codon 11 mutation resulting in substitution of alanine with threonine. We failed to find mutations in exons 1 and 2 of the K-RAS or Ha-RAS genes in any case except a single AML with a mutation in codon 61 of the K-RAS gene. Also, no mutations were identified in chronic phase of CML, chronic lymphocytic leukemia. Ph1 positive ALL, non-Hodgkin's lymphoma, Hodgkin's disease, or multiple myeloma. These results indicate that RAS mutations, especially those involving exon 1 of the N-RAS gene, are frequent only in a subset of hematologic malignancies.Keywords
This publication has 12 references indexed in Scilit:
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988
- The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene productNature, 1988
- Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.Proceedings of the National Academy of Sciences, 1988
- Three-Dimensional Structure of an Oncogene Protein: Catalytic Domain of Human c-H- ras P21Science, 1988
- RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.Proceedings of the National Academy of Sciences, 1987
- Mutations of the Kirsten-ras proto-oncogene in human preleukaemiaNature, 1987
- A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic MutantsScience, 1987
- Detection of high incidence of K-ras oncogenes during human colon tumorigenesisNature, 1987
- Isolation of activated ras transforming genes from two patients with Hodgkin's diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985